Novartis Ag NVS
NYSE NVS
$150.15 -0.47 (-0.31%)
As of: Oct 19, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Long-Term Debt Repayments (2017 - 2026)

Updated

Novartis Ag's Long-Term Debt Repayments was -$4 million in Q3 2018.

Analysis

Novartis Ag (NVS) Long-Term Debt Repayments (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 1.00 Mn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 2.00 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 2.46 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 17.00 Mn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 127.25 Bn 99.26 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.00 Mn
Mar 31, 2026 -19.00 Mn
Dec 31, 2025 -1.77 Bn
Sep 30, 2025 -9.00 Mn
Jun 30, 2025 603.00 Mn
Mar 31, 2025 -1.01 Bn
Dec 31, 2024 -10.00 Mn
Sep 30, 2024 -4.30 Bn
Jun 30, 2024 2.15 Bn
Dec 31, 2023 4.45 Bn
Sep 30, 2023 -2.22 Bn
Jun 30, 2023 4.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 2.00 Mn
Sep 30, 2022 -1.50 Bn
Jun 30, 2022 1.08 Bn
Mar 31, 2022 3.00 Mn
Dec 31, 2021 -696.00 Mn
Sep 30, 2021 -2.93 Bn
Mar 31, 2021 -1.47 Bn
API Access

Novartis Ag Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=NVS&period=max&api_key=YOUR_API_KEY